Shares of Hims & Hers Health (NYSE: HIMS) are falling on Friday. The company's stock lost 23.2% as of 1 p.m. ET and lost as ...

Hims & Hers Health, Inc. (NYSE:HIMS) announced the acquisition of a California-based peptide facility to enhance its domestic ...

Shares of Hims & Hers Health plunged Friday after the Food & Drug Administration said a shortage of the active ingredient in ...

Violin teacher Constance Meyer’s chronic hacking cough was driving other people crazy. The mother of a new student figured ...

Rosa Parks was an avid yoga practitioner. The way Parks took a stand for civil rights reflects many of the principles behind ...

Semaglutide is a glucagon-like peptide-1 (GLP-1) that helps regulate blood sugar levels. Because of outsized demand for ...

Shares tumbled 21% to $52.22. Over the last year, the stock has surged more than 450%.

What Happened? Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 24% in the afternoon session after U.S. Food ...

The Food and Drug Administration on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and ...

Now Medicaid work requirements may be coming back soon as part of a proposed $2.3 trillion spending cut to the program. Trump ...

The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk's popular weight-loss and ...

The FDA just slammed the door on its booming weight-loss drug business--but Hims & Hers has a bold new strategy.